Professional Documents
Culture Documents
Formal education
2008: dr. , Universitas Indonesia
2014: Sp.PD, Universitas Indonesia
2018: K-PTI, Universitas Indonesia
2021-now: PhD – DPhil ClinMed., University of Oxford, UK
Informal education
2015:
Clinical training on Transplant-Oncology-
Immunocompromised Host Infectious Diseases,
Singapore General Hospital, Singapore
2018-2021:
Clinical Epidemiology, Julius Centre UMC Utrecht,
University College of London and
Autonomous University of Barcelona
Robert Sinto
Division of Tropical and Infectious Diseases
Department of Internal Medicine
Faculty of Medicine Universitas Indonesia
Jakarta, February 2022
Outline
• Magnitude of problem
• Dengue infection diagnosis
• Conclusion
Dengue-COVID 19 Co-infection
INDIA:
Tsheten et al. BMC Infectious Diseases (2021) 21:729
PLOS Neglected Tropical Diseases 14(8): e0008426.
https://doi.org/10.1371/journal.pntd.0008426
Co-infection Guideline from India
Co-infection
Guideline from
India
https://www.mohfw.gov.in/pdf/GuidelinesformanagementofcoinfectionofCOVID19
withotherseasonalepidemicpronediseases.pdf
http://dbd.bmkg.go.id/
http://dbd.bmkg.go.id/
http://dbd.bmkg.go.id/
Outline
• Magnitude of problem
• Dengue infection diagnosis
• Conclusion
Classification of Dengue Infection
1997 2009 2011
Dengue fever Dengue without warning Dengue fever
signs
DHF grade I Dengue with warning DHF grade I
signs
DHF grade II DHF grade II
DHF grade III Severe dengue DHF grade III
( severe plasma leakage,
severe hemorrhage,
severe organ involvement)
DHF grade IV DHF grade IV
Expanded dengue
syndrome
Classification of Dengue Infection
1997 2009 2011
Dengue fever Dengue without warning Dengue fever
signs
DHF grade I Dengue with warning DHF grade I
signs
DHF grade II DHF grade II
DHF grade III Severe dengue DHF grade III
( severe plasma leakage,
severe hemorrhage,
severe organ involvement)
DHF grade IV DHF grade IV
Expanded dengue
syndrome
Manifestations of Dengue Infection: 2011
WHO SEARO. Comprehensive guidelines for prevention and control of dengue and DHF. 2011
Diagnosis of Dengue Fever
Probable diagnosis
Acute febrile illness with > 2 of the following:
• headache • retro-orbital pain
• myalgia • arthralgia/bone pain
• rash • haemorrhagic manifestations
• leucopenia (wbc ≤5000 cells/mm3)
• thrombocytopenia (platelet count <150 000 cells/mm3)
• rising haematocrit (5 – 10%);
and at least one of following:
• supportive serology on single serum sample: titre ≥1280
with HAI test, IgG titre with ELISA, or IgM antibody test
• occurrence at the same location and time as confirmed cases
of dengue fever.
WHO SEARO. Comprehensive guidelines for prevention and control of dengue and DHF. 2011
Diagnosis of Dengue Fever (cont’..)
Confirmed diagnosis
Probable case with at least one of the following:
Isolation of dengue virus from serum, CSF or autopsy
samples
↑> 4X serum IgG or in IgM antibody specific to dengue
virus
Detection of dengue virus or antigen in tissue, serum or
CSF by immunohistochemistry, immunofluorescence or
ELISA
Detection of dengue virus genomic sequences by RT-PCR
WHO SEARO. Comprehensive guidelines for prevention and control of dengue and DHF. 2011
Warning Sign of Dengue Infection
WHO 2009 WHO SEARO 2011
No clinical improvement or
Abdominal pain or worsening of the situation as the
tenderness disease progresses
Persistent vomiting Persistent vomiting, not drinking
Severe abdominal pain
Clinical fluid accumulation Lethargy and/or restlessness,
Mucosal bleed sudden behavioural changes
Bleeding: epistaxis, black stool,
Lethargy, restlessness haematemesis, excessive
menstrual bleeding,
Liver enlargement >2 cm haemoglobinuria or haematuria
Laboratory: increase in Giddiness
HCT concurrent with rapid Pale, cold and clammy hands and
feet
decrease in platelet count Less/no urine output for 4–6
hours
WHO. Dengue: guidelines for diagnosis, treatment, prevention and control. 2009
WHO SEARO. Comprehensive guidelines for prevention and control of dengue and DHF. 2011
The Course of Dengue Illness
WHO. Dengue: guidelines for diagnosis, treatment, prevention and control. 2009
Virus, Antigen and Antibody Profile
WHO SEARO. Comprehensive guidelines for prevention and control of dengue and DHF. 2011
Serial ultrasonography, in contrast to existing
markers such as hematocrit, may better identify
patients at risk for development of severe dengue.
Diagnosis of DSS
DHF with signs of shock:
Tachycardia, cool extremities, delayed capillary refill, weak
pulse, lethargy or restlessness, which may be a sign of
reduced brain perfusion
Pulse pressure ≤20 mmHg with increased diastolic
pressure
Hypotension by age, defined as systolic pressure <80 to
90 mmHg for older children and adults
WHO SEARO. Comprehensive guidelines for prevention and control of dengue and DHF. 2011
PLOS Neglected Tropical Diseases 14(8): e0008426.
https://doi.org/10.1371/journal.pntd.0008426
PLOS Neglected Tropical Diseases 14(8): e0008426.
https://doi.org/10.1371/journal.pntd.0008426
International Journal of Infectious Diseases 102 (2021) 152–154
Conclusion
• Dengue and COVID-19 infections shared similar
characteristics.
• Co-infections of both are exist.
• Evaluation of clinical and laboratory
characteristics, supported by “rapid” diagnosis is
the first important step.